Advanced Prostate Cancer Consensus Conference (APCCC)
The Advanced Prostate Cancer Consensus Conference (APCCC) brings together leading experts to discuss areas of uncertainty in managing advanced prostate cancer. The meeting focuses on situations where evidence is limited and aims to provide clarity through structured discussions, debates, and consensus building.
| Organiser | Advanced Prostate Cancer Society |
|---|---|
| Venue | Palazzo dei Congressi |
| Location | Lugano, Switzerland |
The Advanced Prostate Cancer Consensus Conference (APCCC) offers a structured forum for addressing key questions in the management of advanced prostate cancer. Rapid developments in treatments, imaging, biomarkers, and molecular testing have created complex decision-making scenarios for clinicians, often with limited high-level evidence. During two days of presentations, discussions, and debates, international experts review current knowledge, highlight areas of uncertainty, and examine options for individual patient care.
The consensus panel, consisting of more than 100 specialists, contributes to the programme as speakers and moderators. Their discussions focus on predefined clinical questions covering locally advanced disease, biochemical recurrence, and metastatic prostate cancer. After the meeting, the panel’s recommendations are summarised in a manuscript published in European Urology. Attendees are invited to engage actively with the panel throughout the conference.